Umoja Biopharma
Private · United States
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials
Trials
3 active
3 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Aug 2031Phase 1/2 trial completes | |||
| Next date | Aug 2031 · Phase 1/2 trial completes | ||||
| Also tested for | Lymphoma, B Cell, Lymphoma Non-Hodgkin and 5 more | ||||
| Open drug page | |||||
In vivo CD19 CAR-T, lentiviral |
Phase 1 | Mar 2029Phase 1 trial completes | |||
| How it works | Reprograms the patient's own immune T cells | ||||
| Next date | Mar 2029 · Phase 1 trial completes | ||||
| Also tested for | Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL) and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2029Phase 1 trial completes | |||
| Next date | 31 Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Multiple Myeloma in Relapse, Multiple Myeloma (MM) | ||||
| Open drug page | |||||
About
- SEC filings
- None: Umoja Biopharma is private
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021